Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review

DA Papachristos, S Oon, JG Hanly… - Seminars in Arthritis and …, 2021 - Elsevier
Background The neurological and psychiatric manifestations of systemic lupus
erythematosus (NPSLE) are a heterogeneous group of conditions with variable clinical …

The therapeutic strategies for SLE by targeting anti-dsDNA antibodies

Y Wang, S Xiao, Y Xia, H Wang - Clinical reviews in allergy & immunology, 2022 - Springer
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by
diverse serological autoantibodies. Anti-dsDNA antibodies are involved in multiple organ …

Neuropsychiatric systemic lupus erythematosus: molecules involved in its imunopathogenesis, clinical features, and treatment

AA Justiz-Vaillant, D Gopaul, S Soodeen… - Molecules, 2024 - mdpi.com
Systemic lupus erythematosus (SLE) is an idiopathic chronic autoimmune disease that can
affect any organ in the body, including the neurological system. Multiple factors, such as …

Pain without inflammation in rheumatic diseases

J Lampa - Best practice & research Clinical rheumatology, 2019 - Elsevier
Chronic pain is a common symptom in rheumatic diseases, and the patient with pain and no
signs of inflammation poses a challenge to the physician. Notably, all rheumatic diseases …

Attribution of neuropsychiatric symptoms and prioritization of evidence in the diagnosis of neuropsychiatric lupus: mixed methods analysis of patient and clinician …

M Sloan, L Andreoli, MS Zandi, R Harwood… - …, 2023 - academic.oup.com
Objective Neuropsychiatric lupus (NPSLE) is challenging to diagnose. Many
neuropsychiatric symptoms, such as headache and hallucinations, cannot be verified by …

Biomarkers in neuropsychiatric systemic lupus erythematosus: a systematic literature review of the last decade

J Lindblom, C Mohan, I Parodis - Brain Sciences, 2022 - mdpi.com
Nervous system involvement in patients with SLE, termed neuropsychiatric SLE (NPSLE),
constitutes a diagnostic challenge, and its management is still poorly optimised. This review …

Cognitive dysfunction in systemic lupus erythematosus: a case for initiating trials

N Kello, E Anderson, B Diamond - Arthritis & Rheumatology, 2019 - Wiley Online Library
Cognitive dysfunction (CD) is an insidious and underdiagnosed manifestation of systemic
lupus erythematosus (SLE) that has a considerable impact on quality of life, which can be …

sTREM-1 promotes the phagocytic function of microglia to induce hippocampus damage via the PI3K–AKT signaling pathway

L Lu, X Liu, J Fu, J Liang, Y Hou, H Dou - Scientific Reports, 2022 - nature.com
Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is a soluble form of
TREM-1 released during inflammation. Elevated sTREM-1 levels have been found in …

Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndrome

AB Tjensvoll, MB Lauvsnes, H Zetterberg, JT Kvaløy… - Journal of …, 2021 - Springer
Background To test the hypothesis that neurofilament light (NfL) in CSF is a biomarker of
CNS involvement in patients with systemic lupus erythematosus (SLE) and primary …

The diverse and complex modes of action of anti-NMDA receptor autoantibodies

LP Wollmuth, K Chan, L Groc - Neuropharmacology, 2021 - Elsevier
NMDA receptors are ligand-gated ion channels that are found throughout the brain and are
required for both brain development and many higher order functions. A variety of human …